From tracking steps and sleep to genetic testing and digital health records, the interaction between countless technologies and personal health information has opened a new frontier in personalized medicine. Industry analysts are predicting outcomes ranging from improved access to health care services at reduced costs to heightened risk to patient lives where cybersecurity is not designed into health-related technologies to a paradigm shift from disease management to well-being promotion.

Leading women in health care, genetic testing, cybersecurity and venture financing will address these predictions and the critical IP, technology, regulatory, investment, and security issues in personalized medicine.